Startups

Associate Director, Access Strategy and Marketing

Revolution Medicines · Remote (United States) · Remote

← All jobs
About Revolution Medicines

Backed by GV.

About the role

The Associate Director will lead the strategy, development, and execution of access marketing materials for the RevMed portfolio with a focus on pancreatic adenocarcinoma (PDAC) or non-small cell lung cancer (NSCLC). Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree required with 6+ years of experience in Marketing, Product Planning, and/or Managed Care
  • Experience in new product launches, including tactical execution
  • Strong understanding of the access landscape across all market access stakeholders
  • Excellent organizational skills and ability to prioritize and effectively deliver results within established timelines
  • Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication
  • Ability to travel up to 25%
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Associate Director will lead the strategy, development, and execution of access marketing materials for the RevMed portfolio with a focus on pancreatic adenocarcinoma (PDAC) or non-small cell lung cancer (NSCLC).

This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. The...

Read the full posting on Revolution Medicines's site ↗

US Market Access

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.